![](https://cdn.cancerletter.com/media/2024/01/30031303/41-11-McRaven.jpg)
![](https://cdn.cancerletter.com/media/2024/01/30031303/41-11-McRaven.jpg)
Cover Story
There will be no more faculty surveys at MD Anderson, UT System Chancellor William McRaven pledged to the institution's faculty in a closed-door meeting March 18.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center
- Tweaking the existing systems is not the answer to drug shortages